Skip to main content

Table 2 Comorbidities on admission, divided for groups (DSG vs. NDSG)

From: COVID-19 inpatients with gastrointestinal onset: sex and care needs’ differences in the district of Ferrara, Italy

Comorbidity DSG (N = 62) NDSG (N = 433) p value
Hypertension 41 (66.1) 265 (61.2) 0.52
Diabetes 19 (30.6) 89 (20.6) 0.07
Ischemic Heart Disease 5 (8.1) 58 (13.4) 0.23
Heart Failure 1 (1.6) 55 (12.7) 0.009
Chronic Kidney Disease (III-IV-V stage) 8 (12.9) 55 (12.7) 1.00
Stroke or TIA 9 (14.5) 52 (12.0) 0.84
PCOA 5 (8.1) 23 (5.3) 0.38
COPD 0 (0) 45 (10.4) 0.008
Hepatic Steatosis 3 (4.8) 9 (2.1) 0.19
End-stage Liver Disease 2 (3.2) 6 (1.4) 0.29
Localized or Hematological Cancer 15 (24.2) 70 (16.2) 0.13
Metastatic Cancer 6 (9.7) 21 (4.8) 0.12
  1. All data are expressed with number of cases (%)
  2. DGS Digestive Symptoms group, NDGS No Digestive Symptoms Group, TIA Transitory Ischemic Attack, PCOA Peripheral Chronic Obstructive Arteriopathy, COPD Chronic Obstructive Pulmonary Disease